Astrana Health Stock Book Value Per Share
| AMEHDelisted Stock | USD 34.07 0.34 0.99% |
Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.
Astrana |
Astrana Health Company Book Value Per Share Analysis
Astrana Health's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Astrana Health Book Value Per Share | 12.74 X |
Most of Astrana Health's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Astrana Health is about 12.739 times. This is 849.35% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The book value per share for all United States stocks is 99.34% higher than that of the company.
Astrana Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in book value per share category among its peers.
Astrana Fundamentals
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X | |||
| Price To Book | 3.12 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 1.33 B | |||
| Gross Profit | 199.48 M | |||
| EBITDA | 117.97 M | |||
| Net Income | 48.51 M | |||
| Cash And Equivalents | 273.71 M | |||
| Cash Per Share | 6.04 X | |||
| Total Debt | 229.36 M | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 2.49 X | |||
| Book Value Per Share | 12.74 X | |||
| Cash Flow From Operations | 133.87 M | |||
| Short Ratio | 17.16 X | |||
| Earnings Per Share | 1.04 X | |||
| Target Price | 46.56 | |||
| Number Of Employees | 1.36 K | |||
| Beta | 1.04 | |||
| Market Capitalization | 1.86 B | |||
| Total Asset | 966.21 M | |||
| Retained Earnings | 192.68 M | |||
| Working Capital | 287.81 M | |||
| Current Asset | 13.56 M | |||
| Current Liabilities | 7.43 M | |||
| Z Score | 7.27 | |||
| Net Asset | 966.21 M |
About Astrana Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |